Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apremilast for Palmoplantar Pustulosis in Japan
NCT04057937Phase 2Completed
- Sponsor
- Amgen
- Start
- Oct 2019
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apremilast in palmoplantar pustulosis (PPP), sponsored by Amgen. Started Oct 2019; status: completed.
02
Drugs
apremilast
03
Conditions
palmoplantar pustulosis (PPP)
Beyond the preview
Go deeper on NCT04057937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04057937.